Literature DB >> 21520937

Inhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.

Xuemei Wang1, Shanshan Wu, Dingguo Xu, Daiqian Xie, Hua Guo.   

Abstract

Angiotensin-converting enzyme (ACE) is an important zinc-dependent hydrolase responsible for converting the inactive angiotensin I to the vasoconstrictor angiotensin II and for inactivating the vasodilator bradykinin. However, the substrate binding mode of ACE has not been completely understood. In this work, we propose a model for an ACE Michaelis complex based on two known X-ray structures of inhibitor-enzyme complexes. Specifically, the human testis angiotensin-converting enzyme (tACE) complexed with two clinic drugs were first investigated using a combined quantum mechanical and molecular mechanical (QM/MM) approach. The structural parameters obtained from the 550 ps molecular dynamics simulations are in excellent agreement with the X-ray structures, validating the QM/MM approach. Based on these structures, a model for the Michaelis complex was proposed and simulated using the same computational protocol. Implications to ACE catalysis are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21520937      PMCID: PMC3156973          DOI: 10.1021/ci200083f

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  54 in total

1.  A computational approach to the study of the binding mode of dual ACE/NEP inhibitors.

Authors:  Nikolaos Dimitropoulos; Athanasios Papakyriakou; Georgios A Dalkas; Edward D Sturrock; Georgios A Spyroulias
Journal:  J Chem Inf Model       Date:  2010-03-22       Impact factor: 4.956

2.  Hippuryl-L-histidyl-L-leucine, a substrate for angiotensin converting enzyme.

Authors:  A Vrielink; A Obel-Jorgensen; P W Codding
Journal:  Acta Crystallogr C       Date:  1996-05-15       Impact factor: 1.172

3.  Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity.

Authors:  X Liu; M Fernandez; M A Wouters; S Heyberger; A Husain
Journal:  J Biol Chem       Date:  2001-06-29       Impact factor: 5.157

4.  Solvent effects on protein motion and protein effects on solvent motion. Dynamics of the active site region of lysozyme.

Authors:  C L Brooks; M Karplus
Journal:  J Mol Biol       Date:  1989-07-05       Impact factor: 5.469

5.  Development of effective quantum mechanical/molecular mechanical (QM/MM) methods for complex biological processes.

Authors:  Demian Riccardi; Patricia Schaefer; Yang Yang; Haibo Yu; Nilanjan Ghosh; Xavier Prat-Resina; Peter König; Guohui Li; Dingguo Xu; Hua Guo; Marcus Elstner; Qiang Cui
Journal:  J Phys Chem B       Date:  2006-04-06       Impact factor: 2.991

6.  QM/MM studies of monozinc β-lactamase CphA suggest that the crystal structure of an enzyme-intermediate complex represents a minor pathway.

Authors:  Shanshan Wu; Dingguo Xu; Hua Guo
Journal:  J Am Chem Soc       Date:  2010-12-07       Impact factor: 15.419

7.  Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.

Authors:  Hazel R Corradi; Sylva L U Schwager; Aloysius T Nchinda; Edward D Sturrock; K Ravi Acharya
Journal:  J Mol Biol       Date:  2006-01-31       Impact factor: 5.469

8.  Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.

Authors:  Andreas G Tzakos; Athanassios S Galanis; Georgios A Spyroulias; Paul Cordopatis; Evy Manessi-Zoupa; Ioannis P Gerothanassis
Journal:  Protein Eng       Date:  2003-12

Review 9.  Ace revisited: a new target for structure-based drug design.

Authors:  K Ravi Acharya; Edward D Sturrock; James F Riordan; Mario R W Ehlers
Journal:  Nat Rev Drug Discov       Date:  2003-11       Impact factor: 84.694

10.  Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme.

Authors:  Jean M Watermeyer; Wendy L Kröger; Hester G O'Neill; B Trevor Sewell; Edward D Sturrock
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

View more
  8 in total

1.  QM/MM investigation of the catalytic mechanism of angiotensin-converting enzyme.

Authors:  Xia Mu; Chunchun Zhang; Dingguo Xu
Journal:  J Mol Model       Date:  2016-05-16       Impact factor: 1.810

2.  N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.

Authors:  Elena V Kugaevskaya; Alexander V Veselovsky; Maria I Indeykina; Nina I Solovyeva; Maria S Zharkova; Igor A Popov; Eugene N Nikolaev; Alexey B Mantsyzov; Alexander A Makarov; Sergey A Kozin
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

3.  Identification and Functional Mechanism of Novel Angiotensin I Converting Enzyme Inhibitory Dipeptides from Xerocomus badius Cultured in Shrimp Processing Waste Medium.

Authors:  Xiujun Gao; Xiqi Li; Peisheng Yan; Rui Sun; Guangfeng Kan; Ying Zhou
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

4.  Sequence Identification of Bioactive Peptides from Amaranth Seed Proteins (Amaranthus hypochondriacus spp.).

Authors:  Alexis Ayala-Niño; Gabriela Mariana Rodríguez-Serrano; Luis Guillermo González-Olivares; Elizabeth Contreras-López; Patricia Regal-López; Alberto Cepeda-Saez
Journal:  Molecules       Date:  2019-08-21       Impact factor: 4.411

5.  Identification and Quantitation of Bioactive and Taste-Related Dipeptides in Low-Salt Dry-Cured Ham.

Authors:  Alejandro Heres; Marta Gallego; Leticia Mora; Fidel Toldrá
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

6.  Cryo-EM reveals mechanisms of angiotensin I-converting enzyme allostery and dimerization.

Authors:  Lizelle Lubbe; Bryan Trevor Sewell; Jeremy D Woodward; Edward D Sturrock
Journal:  EMBO J       Date:  2022-07-12       Impact factor: 14.012

7.  A Liquid Chromatography-Tandem Mass Spectrometry Method for Evaluation of Two Brands of Enalapril 20 mg Tablets in Healthy Human Volunteers.

Authors:  Wael Abu Dayyih; Mohammed Hamad; Ahmad Abu Awwad; Eyad Mallah; Zainab Zakarya; Alice Abu Dayyih; Tawfiq Arafat
Journal:  J Anal Methods Chem       Date:  2017-08-15       Impact factor: 2.193

8.  Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study.

Authors:  Amanat Ali; Seham Abdullah Rashed Alzeyoudi; Shamma Abdulla Almutawa; Alya Nasir Alnajjar; Yusra Al Dhaheri; Ranjit Vijayan
Journal:  Biomolecules       Date:  2020-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.